Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 2/20 | 0.55 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3546371 | 1.00 | PDK2 (0.55) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3544093 | 0.89 | PDK2 (0.44) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3544090 | 0.89 | PDK2 (0.44) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3551107 | 0.89 | PDK2 (0.55) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3551111 | 0.89 | PDK2 (0.55) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3544407 | 0.87 | PDK2 (0.50) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3544410 | 0.87 | PDK2 (0.50) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3549086 | 0.87 | PDK2 (0.53) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3549084 | 0.87 | PDK2 (0.53) | PDK2PDE4BPDE4DALDH1A1ROCK2 | |
| SCHEMBL3553165 | 0.86 | PDK2 (0.52) | PDK2PDE4BPDE4DALDH1A1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7691843-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2010-04-06 | — | — | US | disclosed |
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | VICURON HOLDINGS LLC | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058304-A1 | N-hydroxyamide derivatives possessing antibacterial activity | AMDHD2, OGA, ENGASE | PDK2 2445/4885PDE4B 2020/4885PDE4D 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.